The effect of selenase on the disease process  of patients with septic shock admitted to the intensive care unit: A clinical trial in Tehran

Ebrahim  Hazrati; Mohammad Reza Rafii Rafii; behzad kazemi haki; Babak  Shekarchi; Seyed Javad  Hosseini-Shokouh

Annals of Military and Health Sciences Research

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors and Boards Indexing and Listing Sources Reviewer and AE Registration Form Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support

Authors Guide Submit Manuscript

The effect of selenase on the disease process of patients with septic shock admitted to the intensive care unit: A clinical trial in Tehran

Author(s):

Ebrahim Hazrati¹,

Mohammad Reza Rafii Rafii¹,

behzad kazemi haki^2,*,

Babak Shekarchi³,

Seyed Javad Hosseini-Shokouh⁴

1Department of Anesthesiology, AJA University of Medical Sciences, Tehran, Iran, Andorra

2Bachelor of Anesthesiology, Tabriz University of Medical Sciences, Tabriz, Iran, Andorra

3Department of radiology, AJA University of Medical Sciences, Tehran, Iran, Andorra

4Department of Infectious Diseases and Tropical Medicine, AJA University of Medical Sciences, Tehran, Iran., Andorra

Annals of Military and Health Sciences Research:Vol. 13, issue 1; e62678

Published online:Apr 24, 2015

Article type:Research Article

Received:Jan 21, 2015

Accepted:Mar 24, 2015

How to Cite:Ebrahim HazratiMohammad Reza Rafii Rafiibehzad kazemi hakiBabak ShekarchiSeyed Javad Hosseini-ShokouhThe effect of selenase on the disease process of patients with septic shock admitted to the intensive care unit: A clinical trial in Tehran.Ann Mil Health Sci Res.13(1):e62678.

Abstract

Materials and Methods: This double-blind clinical trial was done on 80 participants (40 case and 40 control) who were admitted to the ICU with septic shock. Every participant in the case group was administered 500 μg selenase twice daily for 10 days. In contrast, each participant of the control group was treated with placebo (normal saline). Data were collected by observation and recorded in a questionnaire. Chi-square and Student’s t-test were used for data analysis. Results: In this study 34 participants (42.5%) were men and 46 (57.5%) were women. The duration stay in the ICU in treatment group was less than in the observation group which was statistically significant (P = .01). There was also a significant difference regarding the frequency of morbidity and mortality rates between the two groups (P = .03 and P = .02, respectively). Conclusion: Selenium at a dosage of 500 μg (twice daily) is effective in those who have suffered from septic shock. Still, more studies are needed to determine the best dosage and administration method of this drug.

Keywords

Fulltext

full text is available in PDF.

References

1.
References is available in PDF.

comments